Healthcare provider profile · identity verified

Grace Guerrier, MD

Internal Medicine · BERWICK, PA · NPI 1598257610

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	538	150
Lisinopril	Lisinopril	409	113
Levothyroxine Sodium	Levothyroxine Sodium	401	99
Omeprazole	Omeprazole	353	107
Amlodipine Besylate	Amlodipine Besylate	306	83
Losartan Potassium	Losartan Potassium	279	82
Gabapentin	Gabapentin	229	66
Ozempic	Semaglutide	205	38
Furosemide	Furosemide	199	64
Pantoprazole Sodium	Pantoprazole Sodium	187	50
Rosuvastatin Calcium	Rosuvastatin Calcium	171	53
Duloxetine Hcl	Duloxetine Hcl	164	42
Metoprolol Succinate	Metoprolol Succinate	161	53
Metformin Hcl Er	Metformin Hcl	157	43
Metformin Hcl	Metformin Hcl	156	48
Eliquis	Apixaban	155	34
Montelukast Sodium	Montelukast Sodium	154	44
Sertraline Hcl	Sertraline Hcl	152	38
Hydrochlorothiazide	Hydrochlorothiazide	144	44
Potassium Chloride	Potassium Chloride	136	30
Jardiance	Empagliflozin	135	30
Fluticasone Propionate	Fluticasone Propionate	133	44
Albuterol Sulfate Hfa	Albuterol Sulfate	128	52
Simvastatin	Simvastatin	126	39
Diclofenac Sodium	Diclofenac Sodium	125	45
Pregabalin	Pregabalin	122	24
Metoprolol Tartrate	Metoprolol Tartrate	115	35
Alprazolam	Alprazolam	114	22
Trazodone Hcl	Trazodone Hcl	107	32
Alendronate Sodium	Alendronate Sodium	96	21
Allopurinol	Allopurinol	94	24
Lorazepam	Lorazepam	92	19
Famotidine	Famotidine	89	28
Venlafaxine Hcl Er	Venlafaxine Hcl	84	16
Tramadol Hcl	Tramadol Hcl	82	34
Baclofen	Baclofen	79	35
Clopidogrel	Clopidogrel Bisulfate	79	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	21
Prednisone	Prednisone	75	65
Ropinirole Hcl	Ropinirole Hcl	70	16
Trulicity	Dulaglutide	68	13
Warfarin Sodium	Warfarin Sodium	66	18
Citalopram Hbr	Citalopram Hydrobromide	63	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	23
Buspirone Hcl	Buspirone Hcl	59	18
Sumatriptan Succinate	Sumatriptan Succinate	59	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	58	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	suppressed
Novolog Flexpen	Insulin Aspart	56	19
Atenolol	Atenolol	55	19
Carvedilol	Carvedilol	55	18
Tradjenta	Linagliptin	55	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	17
Repaglinide	Repaglinide	52	18
Tamsulosin Hcl	Tamsulosin Hcl	51	16
Ezetimibe	Ezetimibe	50	16
Escitalopram Oxalate	Escitalopram Oxalate	49	21
Meloxicam	Meloxicam	49	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	48	44
Glipizide	Glipizide	47	11
Synthroid	Levothyroxine Sodium	46	suppressed
Tizanidine Hcl	Tizanidine Hcl	45	14
Glipizide Er	Glipizide	44	13
Spironolactone	Spironolactone	44	14
Triamcinolone Acetonide	Triamcinolone Acetonide	44	24
Amitriptyline Hcl	Amitriptyline Hcl	43	11
Propranolol Hcl	Propranolol Hcl	42	suppressed
Aripiprazole	Aripiprazole	41	15
Torsemide	Torsemide	41	14
Bupropion Xl	Bupropion Hcl	40	13
Donepezil Hcl	Donepezil Hcl	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	14
Azithromycin	Azithromycin	39	29
Doxycycline Hyclate	Doxycycline Hyclate	39	33
Mirtazapine	Mirtazapine	38	14
Breo Ellipta	Fluticasone/Vilanterol	37	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Ibandronate Sodium	Ibandronate Sodium	32	suppressed
Myrbetriq	Mirabegron	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	21
Ondansetron Hcl	Ondansetron Hcl	28	19
Diazepam	Diazepam	27	suppressed
Jantoven	Warfarin Sodium	27	suppressed
Topiramate	Topiramate	26	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	14
Clonidine Hcl	Clonidine Hcl	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Fluconazole	Fluconazole	23	18
Memantine Hcl	Memantine Hcl	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Methylprednisolone	Methylprednisolone	22	22
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	21	suppressed
Amoxicillin	Amoxicillin	20	11
Cephalexin	Cephalexin	20	14
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Sucralfate	Sucralfate	20	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Naproxen	Naproxen	19	suppressed
Nystatin	Nystatin	19	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Buprenorphine	Buprenorphine	18	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Mupirocin	Mupirocin	18	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	18	16
Xarelto	Rivaroxaban	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Premarin	Estrogens, Conjugated	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	16	suppressed
Linzess	Linaclotide	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Klor-Con M10	Potassium Chloride	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Dilantin	Phenytoin Sodium Extended	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Azelastine Hcl	Azelastine Hcl	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Nyamyc	Nystatin	13	suppressed
Unifine Pentips	Pen Needle, Diabetic	13	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Colchicine	Colchicine	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Probenecid-Colchicine	Probenecid/Colchicine	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error